| Title |
An Introduction to Markov Modelling for Economic Evaluation
|
|---|---|
| Published in |
PharmacoEconomics, October 2012
|
| DOI | 10.2165/00019053-199813040-00003 |
| Pubmed ID | |
| Authors |
Andrew Briggs, Mark Sculpher |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Greece | 1 | 25% |
| Uruguay | 1 | 25% |
| New Zealand | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 3 | 75% |
| Science communicators (journalists, bloggers, editors) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 822 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 11 | 1% |
| United States | 8 | <1% |
| Netherlands | 6 | <1% |
| Spain | 4 | <1% |
| Canada | 4 | <1% |
| Colombia | 2 | <1% |
| Ecuador | 2 | <1% |
| Chile | 1 | <1% |
| Kenya | 1 | <1% |
| Other | 13 | 2% |
| Unknown | 770 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 174 | 21% |
| Researcher | 138 | 17% |
| Student > Ph. D. Student | 101 | 12% |
| Other | 53 | 6% |
| Student > Bachelor | 47 | 6% |
| Other | 140 | 17% |
| Unknown | 169 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 251 | 31% |
| Economics, Econometrics and Finance | 117 | 14% |
| Nursing and Health Professions | 44 | 5% |
| Social Sciences | 43 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 30 | 4% |
| Other | 137 | 17% |
| Unknown | 200 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2023.
All research outputs
#1,359,795
of 25,837,817 outputs
Outputs from PharmacoEconomics
#52
of 2,008 outputs
Outputs of similar age
#8,369
of 197,810 outputs
Outputs of similar age from PharmacoEconomics
#8
of 742 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,008 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 197,810 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 742 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.